| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |